Allergen immunotherapy: An effective immune-modifier

International Journal of Immunopathology and Pharmacology

Volumn 12, Issue 1, 1999, Pages 1-5

  Di Gioacchino, M ^a   Cavallucci, E ^a   Di Sciascio, M B ^a   Di Stefano, F ^a   Verna, N ^a   Ramondo, S ^a   Lobefalo, L ^a   Conti, P ^a   Cuccurullo, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Allergy; IgE mediated allergic disease; Immunotherapy

Indexed keywords

ALLERGEN;

ALLERGY; ANAPHYLAXIS; ASTHMA; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032898714     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (40)

1. Cooke R.A., J.H. Barnard, S. Helbald and A. Stull. 1935. Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever). J Exp. Med. 62:733.
2. Litchtenstein L.M., P.S. Norman, W.L. Winkenwerder and A.G. Osler. 1996. In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization. J. Clin. Invest. 45:1126.
3. Fleva A., M. Daniilidis, G. Kyriakopoulou, E. Chatzaki, A. Nikolaou, K. Andreopoulos, J. Daniilidis, A. Tourkantonis and L. Hatzipetrou. 1998. Serum FceRII receptor (SCD23)as an evaluating factor for grass pollen immunotherapy. Int. J. Immunopathol. Pharmacol. 11:71.
4. Ahangari G., M. Rakhshan, A. Farhoudi, M.B. Eslami, H. Mortazavi and P. Pakzad. 1998. The presence and clearance of immune complexes in the intreated generalized psoriasis. Int. J. Immunophatol. Pharmacol. 11:91.
5. Ortolani. C., E.A. Pastorello, C. Incorvaia et al. 1994. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy 49:13.
6. Boscolo P., M. Di Gioacchino, M. Cervone, F. Di Giacomo, E. Ballone and G. Giuliano. 1996. Immunologycal effects of dust containing metals and compounds in workers of a plant producing plastic materials. Preliminary study. Int. J. Immunopathol. Pharmacol. 9:13.
7. Macchi B., S. Grelli, C. Favalli, M. De Carli, E. Garaci and A. Mastino. 1997. Characteristics of interleukin 2 and interleukin 4-dependent cell lines infected with HTLV-1 in vitro. Int. J. Immunopathol. Pharmacol. 10:189.
8. Gleich G.J., B.S. Zimmerman, L.L. Henderson and J.W. Yuginger. 1982. Effects of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six years prospective study. J. Allergy Clin. Immunol. 70:261.
9. Otsuka H., A. Mezawa, M. Ohnishi, K. Okubo, H. Seki and M. Okuda. 1991. Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy 21:115.
10. Creticos P.S., N. Jr Franklin Adkinson, A. Kagey-Sobotka et al. 1985 Nasal challenge with ragweed in hayfever patients: effects of immunotherapy. J. Clin. Invest. 76:2247.
11. Chosay J.G., G.E. Winterrowd, S.K. Shields, L.M. Sly, J.M. Justen, K.A. Ready, N.D. Staite, J.E. Chin and C.J. Dunn. 1998. Novel expression of functional A4, B1 and B7 integrins on neutrophils in bone marrow, blood, and inflamed mouse pleural cavity. Int. J. Immunopathol. Pharmacol. 11:1.
12. Conti P., M. Reale, R. C. Barbacane, S. Frydas, M. Felaco, A. Grilli, F.C. Placido, I. Cataldo, C. Feliciani, M. Di Gioacchino, G. Anogianakis, D. Dimitriadou, D. Vacalis and A. Trakatelis. 1997. Massive infiltration of basophilic cells in inflamed tissue after iniection of rantes. Immunol. Lett. 58:101
13. Oppenheim J.J., A. Loyd, D. Taub et al. 1994. Attractive properties of chemokines and their receptors. Int. J. Immunopathol. Pharmacol. 7:219.
14. Reale M., S. Frydas, R.C. Barbacane et al. 1996. Generation of monocyte chemotactic protein-1 (MCP-1) by rat peritoneal mast cells after LPS or TNF alpha activation. Int. J. Immunopathol. Pharmacol. 9:109
15. Conti P., C. Barbacane, M. Di Gioacchino and M. Reale. 1998. Will MCP-1 and RANTES take center stage ininflammatory diseases including asthma? Allergy and Asthma Proc. 19:121
16. Durham S.R., S. Ying, V.A. Varney et al. 1996. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4 + lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J. Allergy Clin. Immunol. 97:1356.
17. Hamid Q.A., E. Schotman, M.R. Jacobson, S.M. Walker and S.R. Durham. 1997. Increases in IL-12 messenger RNA + cells accompanying inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol. 99:254.
18. Holt P.G., P.D. Sly and W. Smith. 1998. Sublingual immunotherapy for allergic respiratory disease. Lancet 351:613
19. Passalacqua G., M. Albano, L. Fregonese, A.M. Riccio, C. Pronzato, G. S. Mela and G.W. Canonica. 1998. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351:629
20. BSACI Working Party. Position paper on allergen immunotherapy. 1993. Clin. Exp. Allergy, 23:1.
21. Des-Roches A., L. Paradis, J. Knani et al. 1996. Immunotherapy with a standardised Dermatofagoides pteronissimus extract. V. Duration of efficacy of immunotherapy after its cessation. Allergy 51:430.
22. Des-Roches A., L. Paradis, J.L. MËnardo, S. Bouges, J.P. DaurËs and J. Bousquet. 1997. Immunotherapy with a standardised Dermatofagoides pteronissimus extract. VI. Specific immunotherapy prevents the onset of new sensitisations in children. J. Allergy Clin. Immunol. 99:450.
23. Jacobsen L., S. Dreborg, C. Moller et al. 1996. Immunotherapy as a preventive treatment. J. Allergy Clin. Immunol. 97:232
24. Adkinson N.F. Jr, P.A. Eggleston, D. Eney et al. 1997. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336:324.
25. Bonini S. and G. Rasi. 1997. Who benefit from immunotherapy? Allergy; 52:693.
26. Grammer L.C., M.A. Shaughnessy, I.M. Suszko, J.J. Shaughnessy and R. Patterson. 1984. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J. Allergy Clin. Immunol. 73:484.
27. Mosbech H. and O. Osterballe. 1988 Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 43: 523.
28. Norman P.S., P.S. Creticos and D.G. Marsh. 1990. Frequency of booster injection of allergoids. J. Allergy Clin. Immunol. 85:88.
29. Hedlin G., H. Heilborn and G. Lilja et al. 1995. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J. Allergy Clin. Immunol. 96:879.
30. Jacobsen L., B. Nuchel-Petersen, J.A. Whil, H. Lowenstein and H. Ipsen. 1997. Immunotherapy with partially purified and standardised tree pollen extracts. IV-Results from long-term (6 years) follow-up. Allergy 52:914.
31. Durham, S.R., V. Varney, M. Gaga, A.J. Frew, M. Jacobson, A.B. Kay. In press. Grass pollen immunotherapy remains effective 3 years after discontinuation: double bind, placebo-controlled withdrawal study. Clin. Exp. Allergy.
32. Ebner C., D. Kraft and H. Ebner. 1994. Booster immunotherapy (BIT). Allergy 49:38.
33. Lockey R.F., L.M. Benedict, P.C. Turkeltaub and S.C. Bukantz. 1987. Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 79:660.
34. Stewart G.E. II and R.F. Lockey. 1992. Systemic reactions from allergen immunotherapy. J. Allergy Clin. Immunol. 90:567.
35. Sabbah A., S. Hassoun, J. Le Sellin, C. Andre and H. Sicard. 1994 A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 49:309.
36. Joseph B.Z., R. Beam, R.J. Martin and L. Borish. 1995. Prednisone inhibits leykocyte granule secretion into the asthmatic airway. Int. J. Immunopathol. Pharmacol. 8:23.
37. Troise C., S. Voltolini, A. Canessa, S. Pecora and A.C. Negrini. 1995. Sublingual immunotherapy in parietaria pollen induced rhinitis: a double blind study, J. Invest. Allergol. Clin. Immunol. 5:25.
38. Bagnasco M., G. Mariani, G. Passalacqua et al. 1997. Absorption and distribution kinetics of the major Parietaria judaica allergen (Parj 1) administered by noninjectable routes to healthy human beings. J. Allergy Clin. Immunol. 100:121.
39. Holt P.G. 1994. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol. Today 15:484.
40. Bruno G., P. Andreozzi, A. Bagalino and U. Graf. 1997. Gastric asthma: a vagally-mediated disease. Int. J. Immunopathol. Pharmacol. 10:195.